SM

Sanchit Mehrotra

Active Director Director DIN 10978115
DIN 10978115 First appointment Mar 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Sanchit Mehrotra

Data last updated:

Sanchit Mehrotra is a Director at Healthqure Healthtech Private Limited (since 2025) and Director at Cardioexpert Healthtech Private Limited (since 2025). The companies operate in Healthcare.

DIN 10978115
Primary Designation Director
Industry Healthcare
First Appointment 01 Mar 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Aug 20252025Active
Director01 Mar 20252025Active

Board colleagues of Sanchit Mehrotra

Directorship timeline

Open interactive timeline →
Healthqure Healthtech Private Limited
Cardioexpert Healthtech Private Limited
Premium access

Shareholding and investment profile for Sanchit Mehrotra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanchit Mehrotra

Sanchit Mehrotra currently holds 2 directorships: Healthqure Healthtech Private Limited (Director, since 26 Aug 2025); Cardioexpert Healthtech Private Limited (Director, since 01 Mar 2025).

Sanchit Mehrotra was first appointed on 01 Mar 2025 as Director at Cardioexpert Healthtech Private Limited.

The current boards of Sanchit Mehrotra's companies include Sanjay Mehrotra (Healthqure Healthtech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available